BMC Pulmonary Medicine Q2
Unclaimed
BioMed Central Ltd
United Kingdom
BMC Pulmonary Medicine is a journal indexed in SJR in Pulmonary and Respiratory Medicine with an H index of 79. It is an CC BY + CC0 Journal with a Single blind Peer Review review system, and It has a price of 2190 €. The scope of the journal is focused on pulmonary medicine. It has an SJR impact factor of 0,773 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,773.
BMC Pulmonary Medicine focuses its scope in these topics and keywords: asthma, patients, pulmonary, arterial, effects, lung, findings, fluticasone, function, gapshighsensitive, ...
Type: Journal
Type of Copyright: CC BY + CC0
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -



Categories:
Pulmonary and Respiratory Medicine (Q2)
Price
2190 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,773
SJR Impact factor79
H Index503
Total Docs (Last Year)1214
Total Docs (3 years)17692
Total Refs3382
Total Cites (3 years)1211
Citable Docs (3 years)2.56
Cites/Doc (2 years)35.17
Ref/DocOther journals with similar parameters
Annals of Allergy, Asthma and Immunology Q2
Journal of Asthma and Allergy Q2
Current Opinion in Pulmonary Medicine Q2
Chronic Obstructive Pulmonary Diseases Q2
Neurobiology of Sleep and Circadian Rhythms Q2
Compare this journals
Comments